Skip to main content
. 2014 Jun 25;31(9):1155–1160. doi: 10.1007/s10815-014-0281-5

Table 1.

Demographic characteristics of patients

Characteristic TFF cycles (n = 136) Embryo transfer cycles (n = 36) Recurrent TFF cycles (n = 25) p-value
Female age (years) 33.2 ± 0.5 32.7 ± 0.9 32.7 ± 0.8 0.91
BMI (kg/m2) 25.9 ± 0.4 25.8 ± 3.6 25.6 ± 0.7 0.86
Day 3 LH (IU/L) 5.1 ± 0.2 5.2 ± 0.5 4.9 ± 0.3 0.96
Day 3 E2 (pg/mL) 45.5 ± 2.3 48.2 ± 4.8 39.5 ± 6.7 0.08
Day 3 FSH (IU/L) 8.6 ± 0.4 7.9 ± 0.5 9.6 ± 1.9 0.99
Indication
Unexplained 72 (52.9) 12 (33.3) 16 (64.0) **
Male Factor 47 (34.5) 15 (41.7) 2 (8.0)
DOR 9 (6.5) 8 (22.2) 5 (20.0)
Tubal Factor 7 (5.1) 1 (2.8) 2 (8.0)
AFC 8.7 ± 0.6 11.1 ± 1.2 9.1 ± 1.6 0.08
Duration of infertility (months) 83.5 ± 5.1 72.6 ± 7.9 89.8 ± 13.2 0.65
Male age (years) 35.6 ± 0.53 35.0 ± 0.9 35.8 ± 1.0 0.062
TPMSC (million) 11.6 ± 1.3 6.1 ± 1.3 14.6 ± 2.3 0.09
Sperm morphology (%) 2.6 ± 0.3 1.7 ± 0.7 5.2 ± 1.5 0.013

TFF, Total fertilization failure; BMI, Body mass index; LH, Luteinizing hormone; FSH, Follicle stimulating hormone; E2, Estradiol; AFC, Antral follicle count; DOR, Decreased ovarian reserve; hCG, Human chorionic gonadotropin; TPMSC, Total progressive motile sperm count

*Data is presented as mean ± Standard error, n(%)

** p-value is not presented because the number of cases in some of the cells are below 5